☆ 4.7 Article

Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway

Erbao Chen et al.

Summary: This study identified CDCA8 as a novel oncogene in hepatocellular carcinoma (HCC) development. High expression of CDCA8 was associated with worse HCC prognosis. In vitro and in vivo experiments demonstrated that CDCA8 inhibition suppressed HCC cell proliferation, colony formation, and migration. Mechanistically, CDCA8 was found to regulate the MEK/ERK pathway and NF-YA to promote HCC progression.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)

添加到收藏夹

Review Cell Biology

Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms

Dandan Li et al.

Summary: Epithelial-mesenchymal transition (EMT) or mesenchymal-epithelial transition (MET) is important in cancer metastasis, and recent studies have shown that EMT is a heterogeneous and dynamic process with intermediary or partial EMT states. Multiple double-negative feedback loops involving EMT-related transcription factors (EMT-TFs) have been identified to regulate the EMT transition state of the cell. This review summarizes the characteristics, biomarkers, and molecular mechanisms of different EMT transition states, as well as the role of EMT transition state in tumor metastasis, with a focus on gastric cancer.

CELL PROLIFERATION (2023)

添加到收藏夹

Article Oncology

Radiotherapy of bone metastases

S. Thureau et al.

Summary: The French society of ontological radiotherapy has updated its recommendations on bone metastases, which are a common treatment for cancer patients. This treatment is relatively simple but effective in reducing pain and managing spinal cord compression. For oligometastatic patients or in cases of reirradiation, more complex stereotactic treatments can be considered with increased vigilance for spinal cord risks.

CANCER RADIOTHERAPIE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Chen Zhang et al.

Summary: Ferroptosis, an iron-dependent form of cell death, plays a crucial role in tumor suppression and has the potential to reverse cancer therapy resistance.

MOLECULAR CANCER (2022)

添加到收藏夹

Review Cell Biology

Tumor Hybrid Cells: Nature and Biological Significance

Maria S. Tretyakova et al.

Summary: Metastasis, driven by tumor cell fusion, is the leading cause of cancer death. The appearance of tumor hybrid cells (THCs) resulting from the fusion of tumor cells with other cells leads to novel properties such as increased proliferation and migration, drug resistance, decreased apoptosis rate, and immune evasion. This review discusses the factors and potential mechanisms involved in THC occurrence, the different types of THCs, and their role in cancer drug resistance and metastasis, as well as potential therapeutic approaches.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Review Oncology

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Qingzhu Jia et al.

Summary: Tumor immunological heterogeneity plays a crucial role in the progression of disease and treatment response, especially in the field of immunotherapy. Recent studies using advanced sequencing and biopsy methods have shown the potential to investigate the complexity and clinical relevance of tumor immunological heterogeneity.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Pathological implication of protein post-translational modifications in cancer

Sheng Pan et al.

Summary: Protein post-translational modifications (PTMs) have a profound impact on protein functions and play a crucial role in cancer biology. The study of PTMs has become an important area in cancer research to understand cancer biology and discover new biomarkers and therapeutic targets. This review discusses some frequently occurring and important PTMs in cancer biology and their implications in clinical applications.

MOLECULAR ASPECTS OF MEDICINE (2022)

添加到收藏夹

Review Oncology

The role of neutrophil extracellular traps in cancer progression, metastasis and therapy

Yue Chen et al.

Summary: This review discusses the role of neutrophil extracellular traps (NETs) in cancer. Research has found that NETs are closely associated with cancer progression, metastasis, and cancer-associated thrombosis. The article summarizes the current understanding of NET formation and explores the potential applications of NETs in cancer therapy.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Oncology

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

Yuhe Huang et al.

Summary: This review describes the molecular mechanisms, signaling pathways, and stages of tumorigenesis involved in the EMT process and discusses the role of EMT in tumor metastasis. It provides new insights and strategies for tumor therapy targeting EMT.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Yi Wang et al.

Summary: Immune checkpoint inhibitors have revolutionized oncology, but only a small percentage of patients benefit from them. Understanding the role of myeloid cells in the tumor microenvironment is crucial for differentiating treatment response from non-response. Recent advancements have provided insights into the heterogeneity and function of myeloid cells, and strategies targeting these cells are being explored in preclinical and clinical settings.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Monocytes in the Tumor Microenvironment

Stefano Ugel et al.

Summary: The review summarizes the current knowledge of the ontogeny, heterogeneity, and functions of monocytes and monocyte-derived cells in cancer, emphasizing the main pathways important for modeling the immunosuppressive tumor microenvironment.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)

添加到收藏夹

Article Oncology

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

Ali Ghoochani et al.

Summary: The study found that mediators of ferroptosis are expressed in treatment-resistant prostate cancer, and treatment with ferroptosis inducers such as erastin and RSL3 can significantly reduce prostate cancer cell growth and migration, potentially serving as novel therapeutic strategies.

CANCER RESEARCH (2021)

添加到收藏夹

Review Immunology

Tumor-associated myeloid cells: diversity and therapeutic targeting

Alberto Mantovani et al.

Summary: Myeloid cells in tumor tissues, including tumor-associated macrophages and tumor-associated neutrophils, play crucial roles in tumor growth and invasion. In recent years, successful therapeutic approaches have been developed and tested in preclinical cancer models, with some strategies reaching clinical trials.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

Youmna Kfoury et al.

Summary: Bone metastases are devastating complications of cancer, particularly common in prostate cancer and refractory to immunotherapy. Analysis of single cells reveals multifaceted immune distortion in metastatic prostate cancer, with overexpression of CCL20 by myeloid cells and appearance of unique macrophages specific to PCa bone metastases. Disruption of the CCL20-CCR6 axis restores T cell reactivity and prolongs animal survival in mice with syngeneic PCa bone metastases, suggesting a targeted approach for relieving local immunosuppression.

CANCER CELL (2021)

添加到收藏夹

Article Oncology

The treatment landscape of metastatic prostate cancer

Yasutaka Yamada et al.

Summary: The treatment landscape of metastatic prostate cancer has significantly evolved with the approval of new drugs and rapid changes in therapy options for patients. Despite improvements in survival and quality of life, prostate cancer remains a leading cause of cancer death globally. Disease heterogeneity and therapy resistance are significant challenges, with early stages of using molecular biomarkers to guide systemic agent selection and sequencing.

CANCER LETTERS (2021)

添加到收藏夹

Review Physiology

BONEMETASTASIS: MECHANISMS, THERAPIES, AND BIOMARKERS

Philippe Clezardin et al.

Summary: Skeletal metastases are common complications of many cancers, significantly impacting patients' quality of life. The multistage process of bone metastasis involves various cellular and molecular mechanisms. While existing bone-targeted agents have made progress, further research and more effective treatment options are still needed.

PHYSIOLOGICAL REVIEWS (2021)

添加到收藏夹

Article Ecology

Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations

Daria Miroshnychenko et al.

Summary: The study demonstrates that spontaneous fusions between cancer cells can lead to partial recombination, increasing heterogeneity and phenotypic plasticity of tumor cells, accelerating their ability to adapt to new selective pressures.

NATURE ECOLOGY & EVOLUTION (2021)

添加到收藏夹

Article Oncology

Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma

Jia-Cheng Lu et al.

Summary: This study revealed that elevated circTMEM181 in HCC patients contributes to poor response to anti-PD1 therapy and prognosis. High levels of exosomal circTMEM181 facilitate an immunosuppressive microenvironment and resistance to anti-PD1 therapy in HCC by sponging miR-488-3p and upregulating CD39 in macrophages. Targeting CD39 in macrophages to inhibit the ATP-adenosine pathway may overcome anti-PD1 resistance in HCC.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019

Longfei Lin et al.

Summary: This study analyzed the mortality and morbidity of 29 types of cancer in 204 countries or regions from 1990 to 2019. It found that the global cancer burden continues to increase, with males having about 1.5 times higher cancer death and incidence rates compared to females. Asia faces the heaviest cancer burden, and the mortality and morbidity of most cancers are related to the development level of countries.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

MiRNA-mediated EMT and CSCs in cancer chemoresistance

Bing Dong et al.

Summary: Cancer stem cells (CSCs) play a crucial role in tumorigenesis and cancer progression, with their generation believed to be driven by epithelial-to-mesenchymal transition (EMT). MicroRNAs (miRNAs) have been found to be key players in this process, and regulating miRNAs associated with EMT or CSCs may help overcome drug resistance.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

Liz J. Hernandez Borrero et al.

Summary: TP53 is the most commonly mutated gene in human cancer with a long history in cancer biology and oncology. Despite advances in understanding the biology and signaling in the p53 pathway, there are still challenges in clinical translation, especially in therapeutic development related to wild-type or mutant p53 activities.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

添加到收藏夹

Article Oncology

19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway

Wei Yu et al.

Summary: The study found that 19-HB inhibits the proliferation, migration, and invasion, and promotes the apoptosis of NSCLC cells through the Wnt/beta-catenin pathway. Additionally, 19-HB inhibited the growth of xenograft tumors in nude mice with limited toxicity to the liver and kidney.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies

Shangli Zhu et al.

Summary: Macrophages are heterogeneous cells that can be classified into M1- and M2-like phenotypes, with M2-like macrophages playing a critical role in tumor microenvironment. They contribute to tumor progression by promoting tumor cell proliferation, angiogenesis, and immunosuppression.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Novel approaches to target the microenvironment of bone metastasis

Lorenz C. Hofbauer et al.

Summary: Bone metastases are a common and severe complication of advanced-stage cancers, particularly in patients with breast and prostate cancer. The interactions between cells in the bone microenvironment affect tumor cell migration, dormancy, and resistance to treatment, and interrupting these interactions can help prevent or treat skeletal metastases.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment

Linbang Wang et al.

Summary: The study revealed the molecular features and functions of TAMs in the tumor microenvironment. It identified important interactions between TAMs and tumor cells and identified the role of hub genes like FLI1 in this process. Finally, the communication between TAMs and immune and stromal cells was confirmed.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Targeting Akt in cancer for precision therapy

Hui Hua et al.

Summary: Biomarkers-guided precision therapeutics has revolutionized the clinical development and administration of molecular-targeted anticancer agents. Tailored precision cancer therapy exhibits better response rate compared to unselective treatment. Protein kinases have critical roles in cell signaling, metabolism, proliferation, survival and migration. Aberrant activation of protein kinases is critical for tumor growth and progression. Consequently, protein kinases are key targets for molecular targeted cancer therapy. The serine/threonine kinase Akt is frequently activated in various types of cancer. Activation of Akt promotes tumor progression and drug resistance. Since the first Akt inhibitor was reported in 2000, many Akt inhibitors have been developed and evaluated in either early or late stage of clinical trials, which take advantage of liquid biopsy and genomic or molecular profiling to realize personalized cancer therapy. Two inhibitors, capivasertib and ipatasertib, are being tested in phase III clinical trials for cancer therapy. This article highlights recent progress of Akt signaling pathway, reviews the up-to-date data from clinical studies of Akt inhibitors and discusses the potential biomarkers that may help personalized treatment of cancer with Akt inhibitors. Additionally, it also discusses how Akt may confer the vulnerability of cancer cells to some kinds of anticancer agents.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Cell & Tissue Engineering

Hypoxia preconditioned bone marrow-derived mesenchymal stromal/stem cells enhance myoblast fusion and skeletal muscle regeneration

Karolina Archacka et al.

Summary: Skeletal muscle reconstruction relies on unipotent stem cells, such as satellite cells, which are activated in response to muscle injury. The study found that bone marrow-derived mesenchymal stromal cells (MSCs) cultured under hypoxic conditions increased VEGF expression and improved myogenesis, leading to enhanced cell engraftment and new vessel formation when transplanted into injured muscles. SDF-1 and VEGF secreted by hypoxia-preconditioned MSCs played a crucial role in cell engraftment and angiogenesis.

STEM CELL RESEARCH & THERAPY (2021)

添加到收藏夹

Review Cell Biology

Cell-Cell Fusion and the Roads to Novel Properties of Tumor Hybrid Cells

Mareike Sieler et al.

Summary: The phenomenon of cancer cell-cell fusion is associated with the origin of more malignant tumor cells exhibiting novel properties, but the whole process and low survivability are not well understood. Post-fusion processes involve random segregation of mixed parental chromosomes and genetic/epigenetic alterations, leading to the occurrence of novel properties as a random event.

CELLS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Tumor angiogenesis: causes, consequences, challenges and opportunities

Roberta Lugano et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cell adhesion in cancer: Beyond the migration of single cells

Michalina Janiszewska et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

添加到收藏夹

Review Oncology

Targeting the MAPK Pathway in KRAS-Driven Tumors

Matthias Drosten et al.

CANCER CELL (2020)

添加到收藏夹

Review Immunology

Myeloid Cell-Derived Arginase in Cancer Immune Response

Tomasz M. Grzywa et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation

Jingjing Wu et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Editorial Material Immunology

Tumor-Derived PGE2 Gives NK Cells a Headache

Nelson H. Knudsen et al.

IMMUNITY (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Treatment of Advanced Prostate Cancer

Min Yuen Teo et al.

ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)

添加到收藏夹

Review Hematology

Neutrophil plasticity in the tumor microenvironment

Morgan A. Giese et al.

BLOOD (2019)

添加到收藏夹

Review Oncology

Mechanisms of PTEN loss in cancer: It's all about diversity

Virginia Alvarez-Garcia et al.

SEMINARS IN CANCER BIOLOGY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells

Clara Fernandes et al.

DRUG DISCOVERY TODAY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis

Xiao Liu et al.

SCIENCE ADVANCES (2019)

添加到收藏夹

Review Oncology

p21 in Cancer Research

Bahar Shamloo et al.

CANCERS (2019)

添加到收藏夹

Review Oncology

Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

Xiangyu Zhang

CANCER COMMUNICATIONS (2019)

添加到收藏夹

Review Cell Biology

EMT Transition States during Tumor Progression and Metastasis

Ievgenia Pastushenko et al.

TRENDS IN CELL BIOLOGY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting Cancer Cell Dormancy

Ariadna Recasens et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

添加到收藏夹

Article Oncology

Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients

Feng Zhao et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Review Pathology

Epithelial Mesenchymal Transition in Tumor Metastasis

Vivek Mittal

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)

添加到收藏夹

Review Oncology

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

添加到收藏夹

Review Cell Biology

Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy

Buqing Sai et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries

Takahiro Kuchimaru et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival

Charles E. Gast et al.

SCIENCE ADVANCES (2018)

添加到收藏夹

Review Oncology

Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape

Malte Mohme et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

添加到收藏夹

Review Medicine, General & Internal

The Diagnosis and Treatment of Prostate Cancer A Review

Mark S. Litwin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Review Oncology

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Tsukasa Shibue et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma

Sarah Schumacher et al.

BRITISH JOURNAL OF CANCER (2017)

添加到收藏夹

Review Oncology

Bone metastasis: the importance of the neighbourhood

Peter I. Croucher et al.

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Review Oncology

Replication stress and cancer

Helene Gaillard et al.

NATURE REVIEWS CANCER (2015)

添加到收藏夹

Review Immunology

Tumor-Associated Macrophages: From Mechanisms to Therapy

Roy Noy et al.

IMMUNITY (2014)

添加到收藏夹

Review Oncology

Mechanisms of disseminated cancer cell dormancy: an awakening field

Maria Soledad Sosa et al.

NATURE REVIEWS CANCER (2014)

添加到收藏夹

Review Oncology

OPINION Challenges in circulating tumour cell research

Catherine Alix-Panabieres et al.

NATURE REVIEWS CANCER (2014)

添加到收藏夹

Article Oncology

Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients

Wolfgang Lilleby et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

CELL (2012)

添加到收藏夹

Article Oncology

Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer

Mercedes Marin-Aguilera et al.

MOLECULAR CANCER THERAPEUTICS (2012)

添加到收藏夹

Article Oncology

Disseminated tumour cells as a prognostic biomarker in colorectal cancer

K. Flatmark et al.

BRITISH JOURNAL OF CANCER (2011)

添加到收藏夹

Review Biochemistry & Molecular Biology

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

Kai Kessenbrock et al.

CELL (2010)

添加到收藏夹

Review Oncology

Cell Fusion as a Hidden Force in Tumor Progression

Xin Lu et al.

CANCER RESEARCH (2009)

添加到收藏夹

Article Cell Biology

Asymmetric focal adhesion disassembly in motile cells

Joshua A. Broussard et al.

CURRENT OPINION IN CELL BIOLOGY (2008)

添加到收藏夹

Article Oncology

Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells

A. Bellahcene et al.

BREAST CANCER RESEARCH AND TREATMENT (2007)

添加到收藏夹

Review Oncology

The clinical significance of disseminated tumor cells in breast cancer

Martin J. Slade et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2007)

添加到收藏夹

Review Cell Biology

Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again

DJ Webb et al.

NATURE CELL BIOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.